Gainers
- DermTech DMTK stock rose 56.6% to $0.18 during Friday's pre-market session. The market value of their outstanding shares is at $6.4 million.
- Sarepta Therapeutics SRPT shares rose 39.26% to $171.99. The market value of their outstanding shares is at $16.2 billion.
- Kintara Therapeutics KTRA shares increased by 17.78% to $0.32. The market value of their outstanding shares is at $17.9 million.
- Solid Biosciences SLDB stock moved upwards by 17.3% to $7.39. The market value of their outstanding shares is at $283.6 million.
- ASLAN Pharma ASLN stock rose 14.06% to $0.36. The market value of their outstanding shares is at $8.2 million.
- Alaunos Therapeutics TCRT shares moved upwards by 13.43% to $0.71. The company's market cap stands at $11.3 million.
Losers
- Psyence Biomedical PBM stock fell 23.9% to $0.46 during Friday's pre-market session. The company's market cap stands at $6.1 million.
- CASI Pharmaceuticals CASI shares fell 23.72% to $2.67. The company's market cap stands at $35.7 million.
- Sonnet BioTherapeutics SONN shares declined by 16.4% to $0.87. The company's market cap stands at $2.7 million.
- Cyclerion Therapeutics CYCN shares decreased by 14.04% to $1.96. The market value of their outstanding shares is at $4.8 million.
- Scinai Immunotherapeutics SCNI shares decreased by 11.48% to $3.47. The company's market cap stands at $2.0 million.
- Sonoma Pharmaceuticals SNOA stock fell 10.69% to $0.18. The market value of their outstanding shares is at $3.4 million. As per the news, the Q4 earnings report came out 4 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CYCNCyclerion Therapeutics Inc
$3.509.72%
PBMPsyence Biomedical Ltd
$2.32-27.0%
SCNIScinai Immunotherapeutics Ltd
$3.32-2.35%
SLDBSolid Biosciences Inc
$4.180.48%
SNOASonoma Pharmaceuticals Inc
$2.49-5.32%
SONNSonnet BioTherapeutics Holdings Inc
$1.41-9.62%
SRPTSarepta Therapeutics Inc
$120.661.42%
TCRTAlaunos Therapeutics Inc
$2.054.59%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in